Literature DB >> 30014306

Classification of thyroid hormone receptor agonists and antagonists using statistical learning approaches.

Fangfang Wang1, Jinyi Xing2.   

Abstract

In silico models are presented for modeling and predicting thyroid hormone receptor (TR) agonists and antagonists. A data set consisting of 258 compounds is used in the present work. The C4.5, random forest (RF) and support vector machine (SVM) statistical methods were used for evaluation. The performance of the quantitative structure-activity relationships was further validated with fivefold cross-validation and an independent external test set. The C4.5 model is slightly weak, and the prediction accuracies of the agonists and antagonists are 93.2 and 57.8% for cross-validation, respectively, averaging 83.1% of correctly classified compounds in the test set. The RF model possesses an average prediction accuracy of 84.0 and 87.1% for the cross-validation and external validation, respectively. Furthermore, the overall prediction accuracy and the external prediction accuracy are 96.6 and 97.2%, respectively, for the SVM model. The results would validate the reliability of the derived models, further demonstrating that RF and SVM models are useful tools capable of classifying TR-binding ligands as agonists or antagonists.

Keywords:  C4.5; RF; SVM; Thyroid hormone receptor

Mesh:

Substances:

Year:  2018        PMID: 30014306     DOI: 10.1007/s11030-018-9857-9

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  2 in total

Review 1.  Review of in silico studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns.

Authors:  Asma Sellami; Manon Réau; Matthieu Montes; Nathalie Lagarde
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

2.  Bisphenol A and thyroid hormones: Bibliometric analysis of scientific publications.

Authors:  Ning Yuan; Li Wang; Xiaomei Zhang; Wei Li
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.